99mTc-HE3-G3

N/A

Report date: 2025/09/24 16:11:31

NME

Base Information

Drug Name99mTc-HE3-G3

Drug Alias Name99mTc-HE3-G399-mTc-HE-3-G-399m-Tc-HE-3-G-399mTc-(HE)3-G399mTc-(CO)3-(HE)3-Ec1 +[6]

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsEpithelial cell adhesion molecule modulators

TargetsReceptor protein-tyrosine kinase erbB-2Epithelial cell adhesion molecule

Therapy Area/IndicationsSolid tumoursBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

Inactive CompaniesN/A

Active IndicationsSolid tumoursBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A